Shay Capital’s LAVA Therapeutics LVTX Stock Holding History

Shay Capital’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,548,730	Closed	-$3.98M	–	564
2025 Q3	$3.98M	Buy	+2,548,730	New	+$3.81M	0.34%	63

Shay Capital's LVTX Position: Q4 2025 in Review

Shay Capital sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 2,548,730 shares — an estimated $3.98M sold.

Shay Capital first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $3.98M in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

Shay Capital reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
Shay Capital sold 2,548,730 LAVA Therapeutics shares in Q4 2025, an estimated $3.98M.
Shay Capital first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
Shay Capital's LAVA Therapeutics position peaked at $3.98M in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on Shay Capital's 13F filing for Q4 2025, filed 17 Feb 2026.